AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Verifica-M 50mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Lupin Ltd

Salt Composition

Metformin (850mg) + Vildagliptin (50mg)

Overview Verifica-M 50mg/850mg Tablet

Combiflex 50mg/850mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Combiflex 50mg/850mg may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a healthy diet and regular physical activity. Dosage is personalized based on individual health status, blood sugar readings, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal upset. Consistent daily dosing, at the same time, maximizes therapeutic benefit and should not be discontinued without physician approval. Effective blood sugar control helps prevent future complications. Maintaining the prescribed diet and exercise regimen is crucial. Lifestyle choices are integral to diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, diaphoresis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication isn't suitable for all individuals. Prior to commencing treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel. Interactions with other medications are possible; disclose all medications to your physician to ensure safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Verifica-M 50mg/850mg Tablet

No text provided to rephrase.

Uses of Verifica-M 50mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Verifica-M 50mg/850mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Verifica-M 50mg/850mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Verifica-M 50mg/850mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Verifica-M 50mg/850mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Verifica-M 50mg/850mg tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

How Verifica-M 50mg/850mg Tablet works:

The dual-action Verifica-M 50mg/850mg tablet combines two anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Verifica-M 50mg/850mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Verifica-M 50mg/850mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Verifica-M 50mg/850mg tablets while breastfeeding is likely inadvisable. Available data in humans indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Verifica-M 50mg/850mg tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Individuals with liver impairment should likely abstain from Verifica-M 50mg/850mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Verifica-M 50mg/850mg Tablet :

Should you forget a Verifica-M 50mg/850mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Verifica-M 50mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Verifica-M 50mg/850mg Tablet

Verifica-M 50mg/850mg tablets rarely cause hypoglycemia by themselves, but low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Verifica-M 50mg/850mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) require immediate medical attention. Do not take other medications without consulting your doctor.
Verifica-M 50mg/850mg Tablets are contraindicated in patients with allergies to any ingredient. This medication should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Verifica-M 50mg/850mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18 years old.
Verifica-M 50mg/850mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Verifica-M if these symptoms occur.
Prolonged use of Verifica-M 50mg/850mg Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Verifica-M 50mg/850mg tablets are safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if you also take insulin or sulphonylurea). Report any persistent side effects to your physician.
Verifica-M 50mg/850mg Tab...
164
MRP 199
17% off